AI assistant
Netramark Holdings Inc. — Board/Management Information 2021
Sep 2, 2021
47953_rns_2021-09-01_f3a183c9-111e-4221-9a68-315e7de379ec.pdf
Board/Management Information
Open in viewerOpens in your device viewer
FORM 51-102F3 MATERIAL CHANGE REPORT
1. Name and Address of Company
Nurosene Health Inc. (the “ Company ”) Suite 101 - 1655 Dupont Street Toronto, ON M6P 3T1
2. Date of Material Change
August 24, 2021
3. News Release
A press release was disseminated on August 25, 2021 via Canada Newswire.
4. Summary of Material Change
The Company appointed George Achilleos as Chief Operating Officer.
5.1 Full Description of Material Change
The Company announced that effective August 24, 2021, George Achilleos was appointed Chief Operating Officer. This is a newly established role within the Company’s leadership team and working in cooperation with the CEO, Ranj Bath, to support the execution of Nurosene’s overall strategic growth initiatives.
Mr. Achilleos brings over 25 years of experience in building and leading multi-million dollar businesses in the technology, e-Commerce and media space. He has most recently served as the President of Origin Scientific, a leader in cannabis nanotechnology solutions. In addition, George had a strong entrepreneurial background having led his own leadership consulting firm and online retailer.
Mr. Achilleos was previously a member of the Company’s advisory board before joining the team in a full-time capacity.
5.2 Disclosure for Restructuring Transactions
Not Applicable.
6. Reliance on Section 7.1(2) or (3) of National Instrument 51-102
Not Applicable.
7. Omitted Information
None
8. Executive Officer
The name of the executive officer of the Company who is knowledgeable about the material change and this report is:
Blake Sing Chief Financial Officer Email: [email protected]
9. Date of Report
September 1, 2021